LISBER has been designed by our experts in the metabolic area for the treatment of the fatty liver or Non Alcoholic  Fatty Liver Disease (NAFDL).
NAFLD refers to the buildup of more fat than necessary in the liver
Doctors do not think that having fat in the liver in and of itself is dangerous in most cases. However, over time, a simple fatty liver may progress to other, more dangerous, liver conditions.
In general, NAFLD is linked to obesity especially in people who have a large waist and associated health conditions, like diabetes.
Most patients have no symptoms from NAFLD, they may feel, more tired than usual or pain in the upper right part of the abdomen
Since this disease rarely has symptoms, the most common way to diagnose fatty liver is by a blood test . Specifically, analysing the liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) that will be increased.

After several years the Lisbiotics team has designed LISBER.

About this product:

LISBER contains artrichoke extract in 500 mg , we use this dose based in in different clinical trials made worldwide.

The artrichoke extract is a powerfurl cholagogue (stimulates the bile production in the liver and promotes emptying of the gall bladder and bile ducts) so the bile drags the fat and the toxic products of the liver, cleansing it

Lisbiotics technicians are always investigating and we have made LISBER after the following clinical trial that shows that the probiotic Bacillus coagulans is effective treating the NAFLD.

The mechanism of action is unclear but a a balanced microbiota makes the digestive system work better and in this way less fat is absorbed.

The combination of the probiotic and the artrichoke extract it is a new and a probed way of treating this disease and  has a powerful and fast effect on the functioning of the liver, cleansing it, decreasing excessive fat and returning it to its normal functioning.


  • Moradi S, Shokri-Mashhadi N, Saraf-Bank S, Mohammadi H, Zobeiri M, Clark CCT, Rouhani MH. The effects of Cynara scolymus L. supplementation on liver enzymes: A systematic review and meta-analysis. Int J Clin Pract. 2021 Nov;75(11):e14726. doi: 10.1111/ijcp.14726. Epub 2021 Aug 23. PMID: 34383355.
  • Abhari K, Saadati S, Yari Z, Hosseini H, Hedayati M, Abhari S, Alavian SM, Hekmatdoost A. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. Clin Nutr ESPEN. 2020 Oct;39:53-60. doi: 10.1016/j.clnesp.2020.06.020. Epub 2020 Jul 24. PMID: 32859329.

Become A Distributor